# Monitoring Metered Dose Inhalation (MDI) Volume and Timing With a Respimetrix Device in Obstructive Lung Disease.

> **NCT05495256** · NA · COMPLETED · sponsor: **Pulmonary Critical Care Associates of Baltimore** · enrollment: 74 (actual)

## Conditions studied

- Asthma
- Copd

## Interventions

- **DEVICE:** Respimetrix

## Key facts

- **NCT ID:** NCT05495256
- **Lead sponsor:** Pulmonary Critical Care Associates of Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-01
- **Primary completion:** 2022-03-22
- **Final completion:** 2022-03-22
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2023-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05495256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05495256, "Monitoring Metered Dose Inhalation (MDI) Volume and Timing With a Respimetrix Device in Obstructive Lung Disease.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05495256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*